Literature DB >> 24959957

Marine actinobacteria: an important source of bioactive natural products.

Panchanathan Manivasagan1, Kyong-Hwa Kang1, Kannan Sivakumar2, Eunice C Y Li-Chan3, Hyun-Myung Oh1, Se-Kwon Kim4.   

Abstract

Marine environment is largely an untapped source for deriving actinobacteria, having potential to produce novel, bioactive natural products. Actinobacteria are the prolific producers of pharmaceutically active secondary metabolites, accounting for about 70% of the naturally derived compounds that are currently in clinical use. Among the various actinobacterial genera, Actinomadura, Actinoplanes, Amycolatopsis, Marinispora, Micromonospora, Nocardiopsis, Saccharopolyspora, Salinispora, Streptomyces and Verrucosispora are the major potential producers of commercially important bioactive natural products. In this respect, Streptomyces ranks first with a large number of bioactive natural products. Marine actinobacteria are unique enhancing quite different biological properties including antimicrobial, anticancer, antiviral, insecticidal and enzyme inhibitory activities. They have attracted global in the last ten years for their ability to produce pharmaceutically active compounds. In this review, we have focused attention on the bioactive natural products isolated from marine actinobacteria, possessing unique chemical structures that may form the basis for synthesis of novel drugs that could be used to combat resistant pathogenic microorganisms.
Copyright © 2014 Elsevier B.V. All rights reserved.

Keywords:  Antibiotics; Bioactive compounds; Chemical structures; Marine actinobacteria; Natural products

Mesh:

Substances:

Year:  2014        PMID: 24959957     DOI: 10.1016/j.etap.2014.05.014

Source DB:  PubMed          Journal:  Environ Toxicol Pharmacol        ISSN: 1382-6689            Impact factor:   4.860


  36 in total

1.  Chrysophanol affords neuroprotection against microglial activation and free radical-mediated oxidative damage in BV2 murine microglia.

Authors:  Fuqing Lin; Chen Zhang; Xianzhen Chen; E Song; Shiyu Sun; Minghui Chen; Tao Pan; Xiaoming Deng
Journal:  Int J Clin Exp Med       Date:  2015-03-15

Review 2.  Genus Nocardiopsis: A Prolific Producer of Natural Products.

Authors:  Ting Shi; Yi-Fei Wang; Han Wang; Bo Wang
Journal:  Mar Drugs       Date:  2022-05-31       Impact factor: 6.085

3.  Complete genome sequence of the actinomycete Actinoalloteichus hymeniacidonis type strain HPA 177T isolated from a marine sponge.

Authors:  Lena Schaffert; Andreas Albersmeier; Anika Winkler; Jörn Kalinowski; Sergey B Zotchev; Christian Rückert
Journal:  Stand Genomic Sci       Date:  2016-12-20

4.  Actinoalloteichus fjordicus sp. nov. isolated from marine sponges: phenotypic, chemotaxonomic and genomic characterisation.

Authors:  Imen Nouioui; Christian Rückert; Joost Willemse; Gilles P van Wezel; Hans-Peter Klenk; Tobias Busche; Jörn Kalinowski; Harald Bredholt; Sergey B Zotchev
Journal:  Antonie Van Leeuwenhoek       Date:  2017-08-02       Impact factor: 2.271

5.  Upregulation and Identification of Antibiotic Activity of a Marine-Derived Streptomyces sp. via Co-Cultures with Human Pathogens.

Authors:  Anne A Sung; Samantha M Gromek; Marcy J Balunas
Journal:  Mar Drugs       Date:  2017-08-11       Impact factor: 5.118

6.  In silico methods for linking genes and secondary metabolites: The way forward.

Authors:  Shradha Khater; Swadha Anand; Debasisa Mohanty
Journal:  Synth Syst Biotechnol       Date:  2016-04-01

Review 7.  Alimentary and Pharmaceutical Approach to Natural Antimicrobials against Clostridioides difficile Gastrointestinal Infection.

Authors:  Miguel Tortajada-Girbés; Alejandro Rivas; Manuel Hernández; Ana González; Maria A Ferrús; Maria C Pina-Pérez
Journal:  Foods       Date:  2021-05-19

8.  Coral-Associated Actinobacteria: Diversity, Abundance, and Biotechnological Potentials.

Authors:  Huda M Mahmoud; Aisha A Kalendar
Journal:  Front Microbiol       Date:  2016-02-29       Impact factor: 5.640

Review 9.  Cyanobacterial Metabolite Calothrixins: Recent Advances in Synthesis and Biological Evaluation.

Authors:  Su Xu; Bhavitavya Nijampatnam; Shilpa Dutta; Sadanandan E Velu
Journal:  Mar Drugs       Date:  2016-01-12       Impact factor: 5.118

10.  Phocoenamicins B and C, New Antibacterial Spirotetronates Isolated from a Marine Micromonospora sp.

Authors:  Mercedes Pérez-Bonilla; Daniel Oves-Costales; Mercedes de la Cruz; Maria Kokkini; Jesús Martín; Francisca Vicente; Olga Genilloud; Fernando Reyes
Journal:  Mar Drugs       Date:  2018-03-16       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.